ESC 365 - PCSK9i: impacting on plaque regression?

Open Access

PCSK9i: impacting on plaque regression?

Session: PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Topic: Atherosclerosis

Speaker: Professor W. Koenig (Munich, DE)

Sponsored by Amgen Cardiovascular

Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)

24 presentations

0 follower

3 more presentations in this session

Introduction - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speaker: Professor J. Kastelein (Amsterdam, NL)

PCSK9i: new horizons in CVD prevention?

Speaker: Professor K. Ray (London, GB)

Conclusion - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speaker: Professor J. Kastelein (Amsterdam, NL)

Access the full session

PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speakers: Professor W. Koenig, Professor J. Kastelein, Professor K. Ray, Professor J. Kastelein

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by